【24h】

Illumina

机译:照度

获取原文
获取原文并翻译 | 示例
           

摘要

Almost 25 years after the Human Genome Project launched, and a little over a decade after it reached its goal of reading all three billion base pairs in human DNA, genome sequencing for the masses is finally arriving. It will no longer be just a research tool; reading all of your DNA (rather than looking at just certain genes) will soon be cheap enough to be used regularly for pinpointing medical problems and identifying treatments. This will be an enormous business, and one company dominates it: Illumina. The San Diego-based company sells everything from sequencing machines that identify each nucleotide in DNA to software and services that analyze the data. In the coming age of genomic medicine, Illumina is poised to be what Intel was to the PC era-the dominant supplier of the fundamental technology.
机译:在人类基因组计划启动后将近25年,以及在其实现读取人类DNA中所有30亿个碱基对的目标之后的大约十年时间里,大规模的基因组测序终于到来了。它将不再仅仅是一种研究工具;读取您所有的DNA(而不是仅查看某些基因)很快就会便宜到可以定期用于查明医疗问题和确定治疗方法。这将是一项巨大的业务,并且由一家公司主导:Illumina。这家位于圣地亚哥的公司出售从识别DNA中每个核苷酸的测序仪到分析数据的软件和服务的所有产品。在即将到来的基因组医学时代,Illumina有望成为英特尔在PC时代的基础技术领域的主要供应商。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号